Australian life science company, QBiotics will present recent positive efficacy data from its completed phase I trial of its lead cancer drug, tigilanol tiglate, at Biotech Showcase. Tigilanol tiglate is a novel small molecule diterpene ester in development as a local treatmen...

Shanghai, January 12, 2020 – Laekna Therapeutics, a clinical-stage biotech company focused on innovative drug development and discovery, today announced that it has scheduled a company presentation at Biotech Showcase™ 2020, to be held January 13–15, during the most important ...

San Francisco/January 12, 2020 – Lowell Therapeutics, Inc., (Lowell) today announced that it has scheduled a company presentation at the Biotech Showcase™ 2020, to be held January 13-15, during the most important week in healthcare at the Hilton San Francisco Union Square. Ja...

San Francisco/January 14, 2020 – NIBEC Co., Ltd., today announced that it has scheduled a company presentation at Biotech Showcase™ 2020, to be held January 13–15, during the most important week in healthcare at the Hilton San Francisco Union Square. Dr. Yoon Jeong Park, CTO w...

CAMBRIDGE, Mass. January 10, 2020 – Vaxess Technologies, an innovative biotechnology company developing a pipeline of therapeutics and vaccines on the MIMIX™ smart release system, announced that it will present at the Biotech Showcase™ 2020, on Wednesday, January 15 at 10:00AM...

Cambridge, UK, 9 January 2020 – Microbiotica, a leading player in microbiome-based therapeutics, confirms its upcoming investor and scientific conference attendance during Q1 2020. Biotech Showcase 2020, 13-15 January 2020, San Francisco, US Held during the week of the JPM Hea...

San Francisco, CA, Jan. 9, 2020 – Quara Devices Inc, is a privately held company with an entirely new technology platform that measures the signature of infectious bacteria, enabling real-time and rapid response in medical, veterinary, pharmaceutical and aquatic applications. ...

SAN FRANCISCO, Jan. 9, 2020 – LACHESIS BIOSCIENCES LTD, a clinical-stage biotechnology company targeting dementia caused by Alzheimer’s and Parkinson’s disease, announced today that its chief executive officer, Dr. Tim Morgan, will present at the Biotech Showcase 2020 confer...

Edmonton, Alberta, Canada, Jan. 9, 2020 – PACYLEX PHARMACEUTICALS, INC. a pre-IND-stage pharmaceutical company targeting hematologic cancers with a new first-in-class therapeutic, announced today that its chief executive officer, Michael Weickert, will present at the Biotech S...

Cancer-focused biotechnology company Kazia Therapeutics will present recent positive interim efficacy data on its lead program, paxalisib, at Biotech Showcase in San Francisco. Paxalisib (formerly known as GDC-0084) is a small molecule inhibitor of the PI3K pathway, which is b...